statistiche ricercatore

Continente	#
NA - Nord America	941
AS - Asia	248
EU - Europa	201
Continente sconosciuto - Info sul continente non disponibili	66
SA - Sud America	52
AF - Africa	18
Totale	1.526

Nazione	#
US - Stati Uniti d'America	923
SG - Singapore	98
IT - Italia	73
CN - Cina	68
BR - Brasile	41
SE - Svezia	36
RU - Federazione Russa	31
HK - Hong Kong	23
BD - Bangladesh	16
GB - Regno Unito	13
FR - Francia	12
IN - India	11
VN - Vietnam	11
FI - Finlandia	9
CA - Canada	7
BE - Belgio	6
DE - Germania	6
CI - Costa d'Avorio	5
MX - Messico	5
VE - Venezuela	5
ID - Indonesia	4
UA - Ucraina	4
ZA - Sudafrica	4
GP - Guadalupe	3
MA - Marocco	3
PL - Polonia	3
UZ - Uzbekistan	3
EG - Egitto	2
ET - Etiopia	2
HR - Croazia	2
IQ - Iraq	2
IR - Iran	2
JP - Giappone	2
PY - Paraguay	2
SV - El Salvador	2
TR - Turchia	2
AR - Argentina	1
BO - Bolivia	1
CO - Colombia	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
ES - Italia	1
GE - Georgia	1
GT - Guatemala	1
HU - Ungheria	1
IE - Irlanda	1
IL - Israele	1
KH - Cambogia	1
LT - Lituania	1
MY - Malesia	1
PK - Pakistan	1
PT - Portogallo	1
SA - Arabia Saudita	1
SC - Seychelles	1
TN - Tunisia	1
Totale	1.461

Nome	#
Preparation of (–)-(R)-2-(2,3,4,5,6-pentafluorophenoxy)-2-(phenyl-d5)acetic acid: an efficient 1H NMR chiral solvating agent for direct enantiomeric purity evaluation of quinoline-containing antimalarial drugs	188
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II	186
Synthesis and evaluation of berberine derivatives and analogs as potential antiacetylcholinesterase and antioxidant agents	183
Antioxidant Activity of Uva di Troia Canosina: Comparison of Two Extraction Methods	179
Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues	174
Stereoselective Modulation of P-Glycoprotein by Chiral Small Molecules	152
Synthesis and Evaluation of Voltage-Gated Sodium Channel Blocking Pyrroline Derivatives Endowed with Both Antiarrhythmic and Antioxidant Activities	145
Gait disturbance and lower limb pain in a patient with PIK3CA-related disorder	139
The Crystal Structure of N-[(2E)-3-(4-Chlorophenyl)prop-2-en-1-yl]-4-methoxy-N-methylbenzenesulfonamide	115
null	65
Totale	1.526

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	61	0	0	0	0	0	10	4	3	5	9	11	19
2022/2023	129	17	22	11	9	11	17	1	18	16	4	0	3
2023/2024	48	3	10	1	8	6	14	0	3	0	1	2	0
2024/2025	162	18	3	14	0	5	17	18	15	4	5	25	38
2025/2026	472	61	22	53	45	72	22	39	3	47	46	20	42
2026/2027	118	15	18	39	42	4	0	0	0	0	0	0	0
Totale													1.526